 Gadolinium
"Gadolinium" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Gadolinium. An element of the rare earth family of metals. It has the atomic symbol Gd, atomic number 64, and atomic weight 157.25. Its oxide is used in the control rods of some nuclear reactors.
| Descriptor ID |
D005682
|
| MeSH Number(s) |
D01.268.477.484 D01.268.558.362.484 D01.552.550.399.484
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gadolinium".
Below are MeSH descriptors whose meaning is more specific than "Gadolinium".
This graph shows the total number of publications written about "Gadolinium" by people in UAMS Profiles by year, and whether "Gadolinium" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 0 | 3 | 3 | | 2021 | 2 | 2 | 4 | | 2020 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 | | 2018 | 1 | 0 | 1 | | 2016 | 2 | 0 | 2 | | 2015 | 0 | 1 | 1 | | 2013 | 1 | 0 | 1 | | 2012 | 0 | 2 | 2 | | 2010 | 0 | 1 | 1 | | 2009 | 1 | 0 | 1 | | 2008 | 1 | 2 | 3 | | 2007 | 2 | 0 | 2 | | 2005 | 0 | 2 | 2 | | 2001 | 0 | 1 | 1 | | 1999 | 1 | 0 | 1 | | 1995 | 0 | 2 | 2 | | 1994 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Gadolinium" by people in Profiles over the past ten years.
-
Subramanian M, Shekar V, Krishnamurthy P, Yalagudri S, Kaur Saggu D, Atreya AR, Chennapragada S, Narasimhan C. Optimizing diastolic filling by pacing in nonobstructive hypertrophic cardiomyopathy. Heart Rhythm. 2023 09; 20(9):1307-1313.
-
Day PL, Wermers M, Pazdernik V, Bornhorst J, Jannetto PJ. Assessment of gadolinium and iodine concentrations in kidney stones and correlation with contrast agent exposure, stone matrix composition, and patient demographic factors. J Trace Elem Med Biol. 2022 Sep; 73:127022.
-
Vidula MK, Xu Z, Xu Y, Alturki A, Reddy BN, Kini P, Alberto-Delgado AL, Jacob R, Chen T, Ferrari VA, Sierra-Galan LM, Chen Y, Viswamitra S, Han Y. Cardiovascular magnetic resonance characterization of rheumatic mitral stenosis: findings from three worldwide endemic zones. J Cardiovasc Magn Reson. 2022 04 07; 24(1):24.
-
Kim C, Park CH, Kim DY, Cha J, Lee BY, Park CH, Kang EJ, Koo HJ, Kitagawa K, Cha MJ, Krittayaphong R, Choi SI, Viswamitra S, Ko SM, Kim SM, Hwang SH, Trang NN, Lee W, Kim YJ, Lee J, Yang DH. Semi-Quantitative Scoring of Late Gadolinium Enhancement of the Left Ventricle in Patients with Ischemic Cardiomyopathy: Improving Interobserver Reliability and Agreement Using Consensus Guidance from the Asian Society of Cardiovascular Imaging-Practical Tutorial (ASCI-PT) 2020. Korean J Radiol. 2022 03; 23(3):298-307.
-
Ayers-Ringler J, McDonald JS, Connors MA, Fisher CR, Han S, Jakaitis DR, Scherer B, Tutor G, Wininger KM, Dai D, Choi DS, Salisbury JL, Jannetto PJ, Bornhorst JA, Kadirvel R, Kallmes DF, McDonald RJ. Neurologic Effects of Gadolinium Retention in the Brain after Gadolinium-based Contrast Agent Administration. Radiology. 2022 03; 302(3):676-683.
-
Henson SE, Lang SM, Khoury PR, Tian C, Rutter MM, Urbina EM, Ryan TD, Taylor MD, Alsaied T. The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy. J Am Heart Assoc. 2021 10 05; 10(19):e021037.
-
Shah CC, Spampinato MV, Parmar HA, Raslan OA, Tom? P, Lin DDM, Vymazal J, Colosimo C, Enterline DS. Safety and diagnostic efficacy of gadoteridol for magnetic resonance imaging of the brain and spine in children 2?years of age and younger. Pediatr Radiol. 2021 Sep; 51(10):1895-1906.
-
Kalantari K, Swaminathan S. Use of Gadolinium in Individuals with Reduced Kidney Function. Clin J Am Soc Nephrol. 2021 02 08; 16(2):304-306.
-
Abo-Aly M, George B, Shokri E, Chelvarajan L, El-Helw M, Smyth SS, Abdel-Latif A, Ziada K. Cangrelor in addition to standard therapy reduces cardiac damage and inflammatory markers in patients with ST-segment elevation myocardial infarction. J Thromb Thrombolysis. 2021 Oct; 52(3):934-940.
-
Bornhorst J, Wegwerth P, Day P, Bryant S, Rokke D, Tervola R, Eckdahl S, Jannetto PJ. Urinary reference intervals for gadolinium in individuals without recent exposure to gadolinium-based contrast agents. Clin Chem Lab Med. 2020 02 25; 58(3):e87-e90.
-
Day P, Erdahl S, Eckdahl S, Bornhorst J, Jannetto PJ. Gadolinium-based contrast agents: A clinically significant analytical interference in inductively coupled plasma mass spectrometry elemental analysis. Ann Clin Biochem. 2019 11; 56(6):638-645.
-
Fitzgerald RT, Agarwal V, Hoang JK, Gaillard F, Dixon A, Kanal E. The Impact of Gadolinium Deposition on Radiology Practice: An International Survey of Radiologists. Curr Probl Diagn Radiol. 2019 May - Jun; 48(3):220-223.
-
Swaminathan S. Gadolinium toxicity: Iron and ferroportin as central targets. Magn Reson Imaging. 2016 Dec; 34(10):1373-1376.
-
Raina S, Lensing SY, Nairooz RS, Pothineni NV, Hakeem A, Bhatti S, Pandey T. Prognostic Value of Late?Gadolinium?Enhancement CMR in?Systemic Amyloidosis. JACC Cardiovasc Imaging. 2016 11; 9(11):1267-1277.
-
Bose C, Megyesi JK, Shah SV, Hiatt KM, Hall KA, Karaduta O, Swaminathan S. Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis. PLoS One. 2015; 10(8):e0136563.
|
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|